One of our current options for the development of new therapeutics for Wolfram syndrome is “drug repurposing.” What is “drug repurposing”? Drug repurposing is the application of known drugs to new diseases. We can save a lot of money and time with this approach. Dr. Freda Lewis-Hall, Chief Medical Officer at Pfizer, discusses this strategy in the following video (39 seconds).
Thank you for reading this blog. I hope you will have a wonderful Monday. I feel that something wonderful is going to happen to us this week.